# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Roth MKM analyst Scott Fortune initiates coverage on ZYUS Life Sciences (TSXV:ZYUS) with a Buy rating and announces Price Ta...
Cannabis multi-state operator Cresco Labs kicked off February by announcing the promotion of Greg Butler to the position of pre...
As the Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, invest...
As Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, investors ...